Chen Xian, Qian ZhiYong, Gou MaLing, Chao GuoTao, Zhang YangDe, Gu YingChun, Huang MeiJuan, Wang JiWei, Pan YiFeng, Wei YuQuan, Chen JianPing, Tu MingJing
State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China.
J Biomed Mater Res A. 2008 Mar 1;84(3):589-97. doi: 10.1002/jbm.a.31350.
In this article, a novel biodegradable and pH-sensitive hydrogel based on polycaprolactone, poly(ethylene glycol) and methylacrylic acid (MAA), was prepared by UV-initiated free radical polymerization. The obtained hydrogel was characterized by (1)H NMR and FTIR. The acute toxicity tests and histopathological study were performed in BALB/c mice. In acute oral toxicity test, mice were orally administered with a total 15 g/kg body weight (b.w.) of P(CL-MAA-EG) hydrogels, and were observed continuously for 14 days. For histopathologic study, samples including heart, liver, lung, kidneys, spleen, stomach, and intestine, were histochemically prepared and stained with hematoxylin-eosin for histopathologic examination. No mortality or significant signs of acute toxicity was observed during the whole observation period, and no macroscopic alteration was found in the organs. Histopathological analysis of various organs also did not show any significant pathological changes. Thus, the maximal tolerance dose of P(CL-MAA-EG) hydrogels was calculated to be higher than 15 g/kg b.w. in BALB/c mice. It was suggested that the studied P(CL-MAA-EG) hydrogel in this article were nontoxic after acute oral administration and it might be a promising candidate as a novel oral drug carrier.
在本文中,通过紫外光引发自由基聚合反应制备了一种基于聚己内酯、聚乙二醇和甲基丙烯酸(MAA)的新型可生物降解且对pH敏感的水凝胶。通过核磁共振氢谱(¹H NMR)和傅里叶变换红外光谱(FTIR)对所得水凝胶进行了表征。在BALB/c小鼠中进行了急性毒性试验和组织病理学研究。在急性经口毒性试验中,给小鼠口服总量为15 g/kg体重(b.w.)的P(CL-MAA-EG)水凝胶,并连续观察14天。对于组织病理学研究,对包括心脏、肝脏、肺、肾脏、脾脏、胃和肠道在内的样本进行组织化学制备,并用苏木精-伊红染色进行组织病理学检查。在整个观察期内未观察到死亡或明显的急性毒性迹象,且在各器官中未发现宏观改变。对各个器官的组织病理学分析也未显示任何明显的病理变化。因此,计算得出P(CL-MAA-EG)水凝胶在BALB/c小鼠中的最大耐受剂量高于15 g/kg b.w.。结果表明,本文所研究的P(CL-MAA-EG)水凝胶经急性经口给药后无毒,可能是一种有前景的新型口服药物载体候选物。